MicroRNA-29a protects against glucocorticoid-induced bone loss and fragility in rats by orchestrating bone acquisition and resorption

Arthritis and Rheumatism

Volumn 65, Issue 6, 2013, Pages 1530-1540

  Wang, Feng Sheng ^a   Chung, Pei Chin ^a   Lin, Chung Liang ^b   Chen, Ming Wen ^a   Ke, Huei Jin ^a   Chang, Yu Hsuan ^a   Chen, Yu Shan ^a   Wu, Shin Long ^a   Ko, Jih Yang ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; GLUCOCORTICOID; GLYCOGEN SYNTHASE KINASE 3BETA; LENTIVIRUS VECTOR; METHYLPREDNISOLONE; MICRORNA 29A; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN KINASE B; SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX2; WNT3A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE FRAGILITY; BONE MASS; CELL DIFFERENTIATION; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HOMEOSTASIS; IMMUNOBLOTTING; MALE; MATERIALS TESTING; MICRO-COMPUTED TOMOGRAPHY; MICROENVIRONMENT; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TRABECULAR BONE; WNT SIGNALING PATHWAY;

ABSORPTIOMETRY, PHOTON; ANIMALS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOCORTICOIDS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICRORNAS; OSTEOBLASTS; OSTEOCLASTS; POLYMERASE CHAIN REACTION; RATS; SIGNAL TRANSDUCTION;

EID: 84878609509     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37948     Document Type: Article

References (47)

1. De Nijs RN, Jacobs JW, Lems WF, Laan RF, Algra A, Huisman AM, et al, for the STOP Investigators. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. N Engl J Med 2006; 355: 675-84.
2. Weinstein RS, Jilka RL, Almeida M, Roberson PK, Manolagas SC,. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice. Endocrinology 2010; 151: 2641-9.
3. Rauch A, Seitz S, Baschant U, Schilling AF, Llling A, Stride B, et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab 2010; 11: 517-31.
4. Kim HJ, Zhao H, Kitaura H, Bhattacharyya S, Brewer JA, Muglia LJ, et al. Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 2006; 116: 2152-60. (Pubitemid 44162324)
5. Yao W, Cheng Z, Busse C, Pham A, Nakamura MC, Lane NE,. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum 2008; 58: 1674-86. (Pubitemid 351847520)
6. Stevens JR, Miranda-Carboni GA, Singer MA, Brugger SM, Lyons KM, Lane TF,. Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells. J Bone Miner Res 2010; 25: 2138-47.
7. Chen JR, Lazareko OP, Wu X, Kang J, Blackburni ML, Shankar K, et al. Dietary-induced serum phenolic acids promote bone growth via p38 MAPK/β-catenin canonical Wnt signaling. J Bone Miner Res 2010; 25: 2399-411.
8. Almeida M, Han L, Ambrogini E, Weinstein RS, Manolagas SC,. Glucocorticoid and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblasts. J Biol Chem 2011; 286: 44326-35.
9. Li X, Gristani M, Fan W, Asuncion FJ, Tan HL, Dwyer D, et al. Dickkopf-1 regulates bone formation in young growth rodents and upon traumatic injury. J Bone Miner Res 2011; 26: 2610-21.
10. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003; 349: 2483-94. (Pubitemid 38010074)
11. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007; 13: 156-63.
12. Weng LH, Wang CJ, Sun YC, Ko JY, Wang FS,. Dickkopf-1 mediates inflammation induction of chondrocyte apoptosis in osteoarthritic joint. Osteoarthritis Cartilage 2009; 17: 919-29.
13. Chen Y, Whetstone HC, Lin AC, Nadesan P, Wei Q, Poon R, et al. β-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med 2007; 4: e249.
14. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
15. Krol J, Loedige I, Filipowicz W,. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 587-610.
16. Sayed D, Hong C, Chen IY, Lypowy J, Adbellatif M,. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 2007; 100: 416-24.
17. Bloomston M, Frankel WJ, Petrocca F, Volinia S, Alder H, Hagan JP, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007; 297: 1901-8. (Pubitemid 46707844)
18. Hornstein E, Mansfield JH, Yekta S, Hu JK, Harfe BD, McManus MT, et al. The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development. Nature 2005; 438: 671-4. (Pubitemid 41740577)
19. Schulman BR, Esquela-Kerscher A, Slack FJ,. Reciprocal expression of lin-41 and the microRNAs let-7 and mir-125 during mouse embryogenesis. Dev Dyn 2005; 234: 1046-54. (Pubitemid 41741176)
20. Luzi E, Marini F, Carbonell Sala S, Tognarini I, Galli G, Brandi ML,. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting the SMAD1 transcription factor. J Bone Miner Res 2008; 23: 287-295. (Pubitemid 351160043)
21. Li Z, Hassan MQ, Volinia S, van Wijen AJ, Stein JL, Croce CM, et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A 2008; 105; 13906-11.
22. Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, et al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 2009; 284: 15676-84.
23. Kapinas K, Kessler CB, Delany AM,. miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J Cell Biochem 2009; 108: 216-24.
24. Kapinas K, Kessler C, Ricks T, Gronowicz G, Delany AM,. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem 2010; 285: 25221-31.
25. Ko JY, Wang FS, Wang CJ, Wong T, Chou WY, Tseng SL,. Increased Dickkopf-1 expression accelerates bone cell apoptosis in femoral head osteonecrosis. Bone 2010; 46: 584-91.
26. Wang FS, Ko JY, Yeh DW, Ke HC, Wu SL,. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss. Endocrinology 2008; 149: 1793-801.
27. Backesjo CM, Li Y, Lindgren U, Haldsosen A,. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J Bone Miner Res 2006; 21: 993-1002. (Pubitemid 43962828)
28. Ko JY, Wu RW, Kuo SJ, Chen MW, Yeh DW, Ke HC, et al. Cannabinoid receptor 1 mediates glucocorticoid-induced bone loss in rats by perturbing bone mineral acquisition and marrow adipogenesis. Arthritis Rheum 2012; 64: 1204-14.
29. Wang FS, Ko JY, Lin CL, Wu HL, Ke HJ, Tai PJ,. Knocking down Dickkopf-1 alleviates estrogen deficiency induction of bone loss: a histomorphological study in ovariectomized rats. Bone 2007; 40: 485-92.
30. Surdziel E, Eder M, Scherr M,. Lentivirus-mediated antagomir expression. Methods Mol Biol 2010; 667: 237-48.
31. Li H, Xie H, Liu W, Hu R, Huang B, Tan YF, et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 2009; 119: 3666-77.
32. Itoh T, Nozawa Y, Akao Y,. MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem 2009; 284: 19272-9.
33. Kahai S, Lee SC, Lee DY, Yang J, Li M, Wang CH, et al. MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS One 2009; 4: e7535.
34. Qiang YW, Chen Y, Stephens O, Brown N, Chen B, Epstein J, et al. Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma. Blood 2008; 112: 196-207.
35. Weng LH, Wang CJ, Ko JY, Sun YC, Wang FS,. Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction and subchondral bone deterioration in osteoarthritic knees. Arthritis Rheum 2010; 62: 1393-402.
36. Kronke G, Uderhardt S, Kim KA, Stock M, Scholtysek C, Zaiss MM, et al. R-spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway. Arthritis Rheum 2010; 62: 2303-12.
37. Wang FS, Wu RW, Ko JY, Tai MH, Ke HC, Yeh DW, et al. Heat shock protein 60 protects skeletal tissue against glucocorticoid-induced bone mass loss by regulating osteoblast survival. Bone 2011; 49: 1080-9.
38. Pederson L, Rau M, Westendorf JJ, Khosla S, Oursler MJ,. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc Natl Acad Sci U S A 2008; 105: 20764-9.
39. Cambardella A, Nagaraju CK, O'Shea PJ, Monhanty ST, Kottam L, Pilling J, et al. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage. J Bone Miner Res 2011; 26: 811-21.
40. Guo J, Liu M, Yang D, Bouxsein ML, Saito H, Galvin RJ, et al. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab 2010; 11: 161-71.
41. Heiland GR, Zwerina K, Baum W, Kireva T, Distler JH, Grisanti M, et al. Neutralisation of Dkk-1 protects from system bone loss during inflammation and reduces sclerostin expression. Ann Rheum Dis 2010; 69: 2152-9.
42. Melton C, Judson RL, Blelloch R,. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells [published erratum appears in Nature 2010;464:126]. Nature 2010; 463: 621-6.
43. Zhang J, Tu Q, Bonewald LF, He X, Stein G, Lian J, et al. Effects of miR-335-5p in modulating osteogenic differentiation by specifically down-regulating Wnt antagonist DKK1. J Bone Miner Res 2011; 26: 1953-63.
44. Mauer B, Stanczyk J, Jungel A, Akhmetshina A, Trenkmann M, Brock M, et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 2010; 62: 1733-43.
45. Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, et al. TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 2011; 22: 1462-74.
46. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011; 53: 209-18.
47. Van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008; 105: 13027-32.